Literaturverzeichnis
- AHIP (2021). New Study: In the Midst of COVID-19 Crisis, 7 out of 10 Big Pharma Companies Spent More on Sales and Marketing than R&D. https://www.ahip.org/news/articles/new-study-in-the-midst-of-covid-19-crisis-7-out-of-10-big-pharma-companies-spent-more-on-sales-and-marketing-than-r-d
- Barenie, Avorn, Tessema, Kesselheim (2021). Public funding for transformative drugs: the case of sofosbuvir. Drug discovery today, 26(1), 273–281. https://doi.org/10.1016/j.drudis.2020.09.024
- Batram, Witte, Greiner, Gensorowsky (2022): AMNOG-Report 2022 Orphan Drugs – Erstattungs- und Versorgungsherausforderungen. In: Storm (2022) Beiträge zur Gesundheitsökonomie und Versorgungsforschung (Band 38). Heidelberg: medhochzwei. https://www.dak.de/dak/download/report-2524570.pdf
- Biontech (2022). BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-fourth-quarter-and-full-year-2021-financial/
- BKK Dachverband (2020). Das teuerste Arzneimittel der Welt ist nun in Deutschland auf dem Markt. https://www.bkk-dachverband.de/versorgung/arzneimittel/das-teuerste-arzneimittel-der-welt-ist-nun-in-deutschland-auf-dem-markt BMBF (2020). Sonderprogramm zur Beschleunigung von Forschung und Entwicklung dringend benötigter Impfstoffe gegen SARS-CoV-2. https://www.gesundheitsforschung-bmbf.de/de/sonderprogramm-zur-beschleunigung-von-forschung-und-entwicklung-dringend-benotigter-12534.php
- Committee on Finance United States Senate (2015). The Price of Sovaldi and Its Impact on the U.S. Health Care System. Committee print S. PRT. 114-20, 114th Congress, 1st Session. https://www.finance.senate.gov/imo/media/doc/1%20The%20Price%20of%20Sovaldi%20and%20Its%20Impact%20on%20the%20U.S.%20Health%20Care%20System%20(Full%20Report).pdf
- Deloitte (2022). Nurturing growth. Measuring the return from pharmaceutical innovation 2021.Deloitte Centre for Health Solutions. https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/deloitte-ch-en-lshc-measuring-the-return-of-pharmaceutical-innovation-2021.pdf
- Deutscher Bundestag, Drucksache 20/454, Antwort der Bundesregierung 20.01.2022 https://dserver.bundestag.de/btd/20/004/2000454.pdf
- Dunleavy (2022). The top 20 drugs by worldwide sales in 2021. Fierce Pharma. https://www.fiercepharma.com/special-reports/top-20-drugs-worldwide-sales-2021
- Ekeigwe (2019). Drug manufacturing and access to medicines: the West African story. A literature review of challenges and proposed remediation. AAPS Open, 5,3. https://doi.org/10.1186/s41120-019-0032-x
- GBA (2021). Beschluss des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII – Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a SGB V Sofosbuvir (neues Anwendungsgebiet: Chronische Hepatitis C, 3 bis < 12 Jahre). BAnz AT 04.03.2021 B2. https://www.g-ba.de/downloads/39-261-4664/2021-01-21_AM-RL-XII_Sofosbuvir_D-562_BAnz.pdf
- Hill, Simmons, Gotham, Fortunak (2016). Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C. Journal of Virus Eradication,2, 28–31. https://www.researchgate.net/publication/289712197
- Jung, Engelberg, Kesselheim (2019). Do large pharma companies provide drug development innovation? Our analysis says no. STAT. https://www.statnews.com/2019/12/10/large-pharma-companies-provide-little-new-drug-development-innovation/
- Kis, Kontoravdi, Dey, Shattock, Shah, (2020). Rapid development and deployment of high-volume vaccines for pandemic response. Journal of advanced manufacturing and processing, 2(3), e10060. https://doi.org/10.1002/amp2.10060
- Novartis (2022). Annual Report 2021. https://www.novartis.com/sites/novartis_com/files/novartis-annual-report-2021.pdf
- Pollack (2015). Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion. The New York Times (3.2.2015). https://www.nytimes.com/2015/02/04/business/sales-of-sovaldi-new-gilead-hepatitis-c-drug-soar-to-10-3-billion.html
- Reuters (2021). Pfizer and Moderna raise prices for COVID-19 vaccines in EU- FT. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-moderna-raises-prices-its-covid-19-vaccines-eu-ft-2021-08-01/
- Schröder, Thürmann, Telschow, Schröder, Busse (2021): Arzneimittel-Kompass 2021. Hochpreisige Arzneimittel – Herausforderung und Perspektiven. Berlin: Springer. https://link.springer.com/book/10.1007/978-3-662-63929-0
- Viciano, Catanzaro (2020). Der Wert des Lebens. Süddeutsche Zeitung, 118, 34-35
- Vieira (2019). Research Synthesis: Public Funding of Pharmaceutical R&D. Knowledge Portal on Innovation and Access to Medicines, Global Health Centre at the Graduate Institute Geneva.https://www.knowledgeportalia.org/_files/ugd/356854_73a1ff84b65642a0926ae81f045b7c5e.pdf
- Wido (2022): Preisentwicklung auf dem Arzneimittelmarkt bis April 2022. GKV-Arzneimittelindex. Berlin: Wissenschaftlichen Instituts der AOK (WldO). https://wido.de/fileadmin/Dateien/Dokumente/Publikationen_Produkte/Arzneimittel-Preisinfo/wido_arz_preisinfo_April_2022.pdf